Let's talk about your next study New study? Request a quote →
Loading...
Bioanalytical CRO

Fit-for-Purpose Biomarker Development

Biomarker assay development built fit for purpose for drug programs, spanning assay design, qualification, and validation for reliable data.

Custom Biomarker Assay Development for Regulatory and Translational Studies

Accelevir designs and validates fit-for-purpose biomarker assays that meet the specific needs of your therapeutic program. Our expertise spans predictive, pharmacodynamic, and safety biomarkers for cell therapy, gene therapy, and vaccine platforms.

Technical Capabilities:

  • Biomarker discovery via multiplex cytokine/chemokine profiling.
  • Flow cytometry-based immune subset and activation marker panels.
  • qPCR/dPCR assays for nucleic acid biomarkers.
  • Custom assay validation under CLIA/GLP conditions.

Why Partner with Accelevir:

  • Deep domain knowledge in immunovirology biomarker development.
  • Ability to scale from discovery to regulated trial testing.